Business Description
Kineta Inc
NAICS : 325412
SIC : 2834
ISIN : US49461C1027
Description
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.27 | |||||
| Equity-to-Asset | -5.82 | |||||
| Debt-to-Equity | -0.09 | |||||
| Debt-to-EBITDA | -0.04 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -39.1 | |||||
| 3-Year EBITDA Growth Rate | -44.1 | |||||
| 3-Year EPS without NRI Growth Rate | 5.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 90.25 | |||||
| 9-Day RSI | 82.78 | |||||
| 14-Day RSI | 75.64 | |||||
| 6-1 Month Momentum % | -46.99 | |||||
| 12-1 Month Momentum % | -90.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.14 | |||||
| Quick Ratio | 0.14 | |||||
| Cash Ratio | 0.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -32 | |||||
| Shareholder Yield % | 54.11 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -175.91 | |||||
| ROA % | -246.64 | |||||
| ROIC % | -388.22 | |||||
| ROC (Joel Greenblatt) % | -4321.5 | |||||
| ROCE % | -28335.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.79 | |||||
| EV-to-EBIT | -0.22 | |||||
| EV-to-Forward-EBIT | -0.52 | |||||
| EV-to-EBITDA | -0.22 | |||||
| EV-to-Revenue | 0.84 | |||||
| EV-to-Forward-Revenue | 1.21 | |||||
| EV-to-FCF | -0.48 | |||||
| Earnings Yield (Greenblatt) % | -454.55 | |||||
| FCF Yield % | -199.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kineta Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.99 | ||
| EPS (TTM) (€) | -1.61 | ||
| Beta | 0 | ||
| Volatility % | 94.11 | ||
| 14-Day RSI | 75.64 | ||
| 14-Day ATR (€) | 0.034556 | ||
| 20-Day SMA (€) | 0.5411 | ||
| 12-1 Month Momentum % | -90.24 | ||
| 52-Week Range (€) | 0.21 - 3.42 | ||
| Shares Outstanding (Mil) | 12.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kineta Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kineta Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kineta Inc Frequently Asked Questions
What is Kineta Inc(STU:J75)'s stock price today?
The current price of STU:J75 is €0.77. The 52 week high of STU:J75 is €3.42 and 52 week low is €0.21.
When is next earnings date of Kineta Inc(STU:J75)?
The next earnings date of Kineta Inc(STU:J75) is 2025-02-21 Est..
Does Kineta Inc(STU:J75) pay dividends? If so, how much?
Kineta Inc(STU:J75) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers